|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, the aim of this research will be to evaluate the effect of supplementation with total anthocyanin-base standardized cornelian cherry fruit extract on liver function (Serum levels of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), cytokeratin-18 fragment M30 (CK-18 M30), as well as steatosis and fibrosis of liver), tumor necrosis factor α (TNF-α), malondealdehyde (MDA), and adiponectin in patients with NAFLD.
|
31324181 |
2019 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
This review attempts to evaluate the usefulness of serum adiponectin, serum leptin, serum ferritin, serum transforming growth factor-β1 (TGF-β1), and serum platelet derived growth factor-BB (PDGF-BB) as non-invasive markers in the diagnosis of liver fibrosis/cirrhosis.
|
30231008 |
2019 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin inhibits hepatic stellate cell (HSC) activation and subsequent development of liver fibrosis via multiple mechanisms.
|
30293572 |
2018 |
|
Fibrosis, Liver
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Adiponectin has antifibrogenic activity protecting from liver fibrosis, which is mainly driven by activated hepatic stellate cells (HSC).
|
27083512 |
2017 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Serum from patients with liver fibrosis was examined for adiponectin and tissue inhibitor of metalloproteinase-1 (TIMP-1) protein.
|
25575598 |
2015 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin, an adipocyte-derived insulin-sensitizing hormone, might play a protective role against hepatic fibrosis.
|
21539538 |
2011 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis.
|
21846328 |
2011 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
We therefore conclude that the protective effects of adiponectin against liver fibrosis require AMPK activation, and may occur through inhibition of the Jak-Stat signal transduction pathway.
|
20564215 |
2010 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin SNPs were found to be associated with the progression of liver fibrosis and insulin resistance, suggesting that adiponectin SNPs might play roles in the occurrence and progression of NAFLD.
|
19484180 |
2009 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin limits the development of liver fibrosis and activates adenosine monophosphate-activated protein kinase (AMPK).
|
18098312 |
2008 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.
|
17462782 |
2007 |